We start by defining the role
The cell business overlaps several areas, each demanding different regulations and facilities. OCELLBIO began by drawing a clear line around what it will be responsible for.
Culture, expansion, cryopreservation, quality testing and batch release of clinical-grade cells are performed by manufacturing facilities licensed under the applicable regulations. OCELLBIO takes responsibility for everything from the moment those cells are received in sealed condition until they are administered at the hospital — identification, incoming inspection, storage, transport and documentation.
A central cell logistics and quality hub
Our facility is designed as a hub that consolidates cell orders from partner clinics, verifies that patient and cell match, holds product at cryogenic temperature and releases it to hospitals under defined temperature conditions.
The essence of the model is that it is not a site handling specimens directly, but a control tower governing transport and handover information.
Five business pillars
Each area operates independently, yet all move on a single system that shares the history data of every cell.
- Cell therapy R&D
- Cell supply and logistics
- Cell storage and bio banking
- Cleanroom and clean booth construction
- Technical standardization
This website is intended to introduce OCELLBIO's business. OCELLBIO Inc. was incorporated in August 2026 and is currently building out its headquarters facility; the facility and equipment specifications shown are design-stage figures and will be finalized during construction and verification. Culture, quality testing and batch release of clinical-grade cells are performed by manufacturing facilities licensed under the applicable regulations, while OCELLBIO is responsible for the storage, logistics and quality documentation of cells handled in sealed condition. Specific terms of cooperation are provided on request.